A member of Alliance Healthcare Group
A member of Alliance Healthcare Group
Early detection matters. Powered by SPOT-MAS™, our Multi-Cancer Early Detection test screens for signals associated with 10 cancers all from one blood sample.
This Multi-Cancer Early Detection screening uses ctDNA (circulating tumour DNA) released from tumour cells, to detect signals associated with multiple cancers from a single blood draw. Research in the performance of SPOT-MAS is clinically validated in Asia, with proven accuracy in cancer signal detection and tumour location prediction.
Powered by SPOT-MAS™.
This test is suitable for individuals who:
This test is intended for screening purposes only and is not diagnostic on its own. A positive result should be followed by further clinical evaluation, which may include appropriate imaging and confirmatory investigations, as advised by a physician.
Convenience: one single blood draw during a healthcare visit.
Early Detection: the potential to identify cancer signals at an early stage.
High Accuracy: high specificity limits false positives and unnecessary work-up.
Efficiency: capability to test for cancers that do not have recommended screenings to improve patient outcomes.
Package Price
(before GST)
Includes Comprehensive
Clinical Examination & Lab Tests
(before GST)
Take a proactive step toward early cancer detection with Alliance OncoScreen 10. Featuring multi-cancer early detection (MCED) with SPOT-MAS 10 by Gene Solutions to assess cancer-associated signals, this comprehensive health screening package includes a full clinical examination to empower you to prioritise preventive health with confidence.
(before GST)
Take a proactive step toward early cancer detection with SPOT-MAS 10 by Gene Solutions. Available as a standalone test, this multi-cancer early detection (MCED) test uses advanced ctDNA detection technology to assess cancer-associated signals and support timely medical follow-up.
Click the following link to find out more about SPOT-MAS™